Juvantia Pharma Ltd Report issue

For profit Phase 2
Founded: Turku Finland (1997)
Status: Acquired by Santhera (2009) → now Bausch Health Companies (2010)

Organization Overview

First Clinical Trial
2007
NCT00559871
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

fipamezole (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Hypotension (Phase 2)

Hypotension, Orthostatic (Phase 2)

Multiple System Atrophy (Phase 2)

Parkinson Disease (Phase 2)

Shy-Drager Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1